Skip to main content

Table 1 Characteristics of the 46 patients with a Resonance stent for MUO

From: The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study

 

Total

Female

Male

(n = 46)

(n = 30)

(n = 16)

Age

 Min.

28

28

43

 Median

67

66

68.5

 Max.

85

81

85

ECOG performance status

 0

26

16

10

 1

14

9

5

 2

4

3

1

 3

2

2

0

Origin

 Gastrointestinal

27

12

15

  Bile/pancreas

6

3

3

  Colon

12

7

5

  Esophagus

1

0

1

  Stomach

8

2

6

 Gynecological

13

13

(−)

  Ovary

4

4

(−)

  Uterine cervix

9

9

(−)

 Other

6

5

1

  Breast

2

2

0

  Malignant Lymphoma

1

1

0

  Peritoneum

1

1

0

  Prostate

1

(−)

1

  Unknown

1

1

0

Metastasis

 No

4

2

2

 Yes

42

28

14

  Lymph node

26

17

9

  Peritoneum

10

7

3

  Pelvic organ

3

3

0

  Liver

2

1

1

  Bone

5

3

2

  Lung

7

4

3

Ascites

 No

30

23

7

 Yes

16

7

9

Pleural effusion

 No

36

25

11

 Yes

10

5

5